INS and amyloidosis: This AAC2–INS complex prevents hypoglycemic episodes and cognitive dysfunction observed in untreated diabetic mice or those treated with free insulin [25]; however, its efficacy in decreasing AD progression and potential side effects, given that both natural and synthetic fibrils carry the risk of exacerbating amyloidosis (reviewed in [27]), have not been examined.